References
- Fauci A. S., Harley J. B., Roberts W. C., Ferrans V. J., Gralnick H. R., Bjorenson B. H. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic and therapeutic considerations. Ann Int Med 1982; 97: 78–92
- Lewis J. C., Yiannias J. A. Cutaneous allergy. Eosinophilia-related syndromes, EN Charlseworth. Blackwell Science Inc., Cambridge 1996; 35–-90
- Weller P. F., Bubley G. J. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759–79
- Romagnani S. Th1 and Th2 in human diseases. Clin Imunol Immunopathol 1996; 80: 225–35
- Schrezenmeier H., Thome S. D., Tewald F., Fleischer B., Raghavachar A. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T-lymphocytes in hyper-eosinophilic syndrome. Exp Hematol 1993; 21: 358–365
- Cogan E., Schandene L., Crusiaux A., Cochaux P., Velu T., Goldman M. Clonal proliferation of type 2 helper T-cells in a man with the hypereosinophilic syndrome. N Engl J Med 1995; 330: 535–8
- Bank I., Reshef A., Beniaminov M., Rosenthal E., Rechavi G., Monselise Y. The role of gamma / delta T-cells in a patient with CD4+CD3- lymphocytosis, hypereosinophilia and high levels of IgE. J Allergy and Clin Immunol 1998; 102: 621–630
- Schandene L., Del Prete G. F., Cogan E., Stordeur P., Crusiaux A., Kennes B., Romaganai S., Goldman M. Recombinant interferon alpha selectively inhibits the production of interleukin-5 by human CD4+ T-cells. J Clin Invest 1996; 97: 309–315
- Brugnoni D., Airo P., Rossi G., Bettinardi A., Simon H-U., Garza L., Tosoni C., Cattaneo R., Blaser K., Tucci A. A case of hypereosinophilic syndrome is associated with the expansion of a CD4+ CD3- T-cell population able to secrete large amounts of interleukin-5. Blood 1996; 87: 1416–22
- Roufosse F., Schandene L., Sibille C., et al. T-cell receptor independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood 1999; 94: 994–1002
- Kraft D. L., Weissman I. L., Waller E. Differentiation of CD3–4+8-human fetal thymocytes in vivo: characterization of a CD3–4+8- intermediate. J Exp Med 1993; 178: 265–277
- de Waal Malefyt R., Yssel H., Spits H., de Vrues J. E., Sancho J., Terhorst C, Alarcon B. Human T-cell leukemia virus type I prevents cell surface expression of the T-cell receptor through down regulation of the CD3-gamma, delta, - epsilon and zeta genes. J Immunol 1990; 145: 2297–2303
- Willard Gallo K. E., Van de Keere F., Kettman R. A specific defect in CD3 gamma chain gene transcription results in los of T-cell receptor / CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci USA 1990; 87: 6713–6717
- Bruno L., Res P., Dessing M., Cella M., Spits H. Identification of a committed T-cell precursor population in adult peripheral blood. J Exp Med 1997; 183: 875–884
- Estes D. M., Turaga P. S., Sievers K. M., Teale J. M. Characterization of an unusual cell type (CD4+CD3-) expanded by helminth infection and related to the parasite stress response. J Immunol 1993; 150: 1846–1856
- Muller K. M., Jaunin F., Masouye I., Saurat J. H., Hauser J. C. Th2 cells mediate IL-4 dependent local tissue inflammation. J Immunol 1993; 150: 5576–84
- O'Shea J. J., Jaffe E. S., Lane H. C., MacDermott R. P., Fauci A.S. Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis. Am J Med 1987; 82: 539–45
- Fischer M. B., Hauber I., Fodinger M, Wolf H. M., Thon V., Donath P., Eibl M. M., Knobler R. M. Defective TCR surface expression associated with impaired TCR beta-chain assembly in a patient with cutaneous T-cell lymphoma. J Invest Dermatol 1995; 104: 537–40
- Roufosse F., Schandene L., Sibille C., Willard-Gallo K., Kennes B, Efira A., Goldman M, Cogan E. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. British J Haematol. 2000; 109: 540–548